selective serotonin reuptake inhibitor (SSRI)
GPTKB entity
Statements (53)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:drug
|
gptkbp:bfsLayer |
6
|
gptkbp:bfsParent |
gptkb:sertraline_hydrochloride
gptkb:Citalopram gptkb:Fluoxetine gptkb:Sertraline |
gptkbp:activities |
inhibiting serotonin reuptake
|
gptkbp:affects |
increased risk of bleeding
possible weight changes potential serotonin syndrome |
gptkbp:can_be |
gptkb:psychologist
support groups lifestyle changes |
gptkbp:contraindication |
MAO inhibitors
|
gptkbp:discovered_by |
1970s
|
gptkbp:example |
gptkb:citalopram
gptkb:escitalopram gptkb:paroxetine fluoxetine sertraline |
https://www.w3.org/2000/01/rdf-schema#label |
selective serotonin reuptake inhibitor (SSRI)
|
gptkbp:influences |
mood
sleep patterns appetite emotional state anxiety levels |
gptkbp:interacts_with |
gptkb:beer
blood thinners other antidepressants NSAI Ds st. john's wort |
gptkbp:is_available_on |
generic medication
brand name medication |
gptkbp:is_effective_against |
chronic pain
schizophrenia ADHD substance use disorders some anxiety disorders |
gptkbp:is_monitored_by |
side effects
suicidal thoughts serotonin syndrome |
gptkbp:is_used_by |
psychiatrists
|
gptkbp:is_used_for |
gptkb:historical_event
anxiety disorders |
gptkbp:side_effect |
nausea
insomnia weight gain sexual dysfunction |
gptkbp:suitable_for |
bipolar disorder
severe liver disease |
gptkbp:symptoms |
dizziness
irritability flu-like symptoms |